• Clinical science

Metal toxicity


Exposure to toxic amounts of heavy metals such as mercury, lead, chrome, and cadmium can be harmful to the human body, potentially causing both acute symptoms (e.g., local irritation, gastroenteritis, and pneumonia) and long‑term effects (e.g., abnormal physical development, cancer, damage to central nervous system, and kidney). Toxic metals have many industrial purposes and therefore represent occupational hazards for a number of professions. Industrial pollution with heavy metals can affect the wider population through the contamination of food (e.g., mercury in fish) and water (e.g., lead, arsenic).

General considerations

  • Chronic exposure to heavy metals generally manifests first as CNS and kidney damage.
  • For chronic diseases resulting from the inhalation of metal dust, see pneumoconiosis.

Overview of principal metal toxicities

Signs and Symptoms Diagnosis Further information Treatment
  • Severe intoxication may cause garlic‑like odor
  • Dimercaprol
  • Succimer (dimercaptosuccinic acid): more commonly used in children
  • Detectable in blood
  • Succimer (Dimercaptosuccinic acid, DMSA)
  • Dimercaprol and/or calcium disodium edetate (CaNa2EDTA)
  • Hemorrhagic gastroenteritis, shock symptoms
  • Neuro- and nephrotoxicity, respiratory depression
  • Clinical
  • Common in pediatric care
  • Blue-violet discoloration along the margins of the gums
  • Neuropsychiatric symptoms including anxiety, abnormal irritability, ataxia, and tremor
  • Gingival and/or buccal inflammation
  • Dimercaprol
  • Succimer (Dimercaptosuccinic acid, DMSA)
  • 2,3 dimercaptopropane-1-sulfonate





  • Sources of exposure
    • Battery manufacturing, metallurgy, corrosion inhibition
    • Gun range
    • Tableware containing lead
    • Drinking water (from lead plumbing or contaminated sources )
    • Antique or imported toys painted with lead-containing paint
  • Action: heme synthesis disruption via inhibition of aminolevulinate dehydratase (catalyzes the conversion of aminolevulinic acid to porphobilinogen)
  • Clinical features
  • Diagnosis
  • Screening in high-risk pediatric populations
    • Living in older housing under renovation or with peeling paint
    • Sibling or playmate with lead poisoning
    • Recent immigrant, refugee, or foreign adoptee
    • History of pica
  • Treatment
    • Decrease exposure: professional lead paint abatement, dust reduction, minimization of contact with bare soil
    • Nutrition: Calcium, iron, zinc, and vitamins C and D-rich diet
    • Chelation therapy indications:
      • Oral succimer with/without intravenous or intramuscular CaNa2EDTA (Calcium disodium ethylenediamine tetraacetic acid)
        • Children with BLL ≥ 45 μg/dl
        • Asymptomatic adults with BLL ≥ 80 μg/dl
        • Symptomatic adults with BLL ≥ 50 μg/dl
      • IM dimercaprol; (British antilewisite, BAL) with/without CaNa2EDTA
        • Patients with lead encephalopathy
        • BLL ≥ 70 μg/dl

ABCDEFGH – Anemia, Basophilic stippling, Colic, Diarrhea, Encephalopathy, Foot drop, Gum deposition/Growth retardation/Gout, Hyperuricemia/Hypertension





  • Definition: chemical element often used as supplement in pediatrics and prenatal care and in the management of anemia
  • Epidemiology: toxicity is common in pediatric care (ingestion of red iron tablets mistaken for candy)
  • Effect: corrosive and toxic effects on cells
  • Clinical features
    • Initially hemorrhagic gastroenteritis, shock symptoms
    • In case patient survives: symptom-free interval after 6 hours
    • Causes dark-colored stools
    • Later: risk of renal and liver failure, unconsciousness, and respiratory depression
  • Diagnostics: anion gap metabolic acidosis
  • Antidote: deferoxamine